op-101
Small moleculeexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Mar 30, 2018 (NCT03500627)
Timeline
Indications
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04458298 | Phase 2 | Jul 1, 2020 | Orpheris, Inc. |
| NCT04321980 | Phase 1 | Mar 19, 2020 | Orpheris, Inc. |
| NCT03500627 | Phase 1 | Mar 30, 2018 | Orpheris, Inc. |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Orpheris, Inc. | For profit | 3 | 3 | 2 | 2018 |
1 organizations
Page 1 / 1